Jalali et al. reported that mTOR inhibition reduced tumor growth rate in pituitary adenomas and more importantly resulted in control of GH expression and IGF-1 secretion in a mouse model [106]. This evidence concerns the gene IGF1 and pituitary gland adenoma.